April 14, 2025 Celularity Welcomes CMS Action on Medicare Local Coverage Determination for Skin Substitutes Products ...
April 7, 2025 Celularity Announces Publication of “Senescence, NK cells, and cancer: navigating the crossroads of aging and disease” in the April 4, 2025, Issue of Frontiers in Immunology ...
February 25, 2025 Celularity Receives FDA Tissue Reference Group Recommendation Letters for its Natalin and Acelagraft™ Wound Care Products ...
February 24, 2025 Celularity Enters Strategic Collaboration Agreement with Clinical Stage Cell Therapy Company ...
Celularity Welcomes CMS Action on Medicare Local Coverage Determination for Skin Substitutes Products
Celularity Announces Publication of “Senescence, NK cells, and cancer: navigating the crossroads of aging and disease” in the April 4, 2025, Issue of Frontiers in Immunology
Celularity Receives FDA Tissue Reference Group Recommendation Letters for its Natalin and Acelagraft™ Wound Care Products
Celularity Enters Strategic Collaboration Agreement with Clinical Stage Cell Therapy Company
MASS Coalition Welcomes Trump Order Freezing Skin Substitute LCDs